Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 13, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 77
- −9 vs. Q2 2024
- Portfolio value
- $644.5M
- +$9.64M (+1.5%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $5.25K | <0.1% | 00.0% | Unchanged | – |
| PMNProMIS Neurosciences Inc. | COM | 30,643 | $38.3K | <0.1% | −235,315−88.5% | Reduced | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 47,019 | $96.9K | <0.1% | +47,019 | New | History |
| GNLXGENELUX Corp | COM | 100,000 | $237.0K | <0.1% | 00.0% | Unchanged | History |
| MTVAMetaVia Inc. | COM | 89,222 | $282.8K | <0.1% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 51,727 | $302.6K | <0.1% | +51,727 | New | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 45,000 | $425.7K | 0.1% | 00.0% | Unchanged | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $430.6K | 0.1% | 00.0% | Unchanged | – |
| ADGMAdagio Medical Holdings, Inc. | COM | 213,235 | $550.1K | 0.1% | +213,235 | New | History |
| KYTXKyverna Therapeutics, Inc. | COM | 119,900 | $586.3K | 0.1% | −80,100−40.1% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 173,351 | $596.3K | 0.1% | +173,351 | New | History |
| PBYIPuma Biotechnology, Inc. | COM | 250,000 | $637.5K | 0.1% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 223,335 | $906.7K | 0.1% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 15,000 | $1.05M | 0.2% | +15,000 | New | History |
| VSTMVerastem, Inc. | COM NEW | 400,000 | $1.20M | 0.2% | +400,000 | New | History |
| QTTBQ32 Bio Inc. | COM | 27,777 | $1.24M | 0.2% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 600,000 | $1.25M | 0.2% | +400,000+200.0% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 25,000 | $1.26M | 0.2% | +25,000 | New | History |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 212,974 | $1.49M | 0.2% | +10,375+5.1% | Added | History |
| TECXTectonic Therapeutic, Inc. | COM | 58,331 | $1.77M | 0.3% | 00.0% | Unchanged | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 300,512 | $1.89M | 0.3% | −200,000−40.0% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 2,511,778 | $1.94M | 0.3% | +750,000+42.6% | Added | History |
| ROIVRoivant Sciences Ltd. | SHS | 201,587 | $2.33M | 0.4% | −150,000−42.7% | Reduced | History |
| NARIInari Medical, Inc. | Stock | 60,000 | $2.47M | 0.4% | −140,000−70.0% | Reduced | History |
| CNTXContext Therapeutics Inc. | COM | 1,321,153 | $2.59M | 0.4% | −297,987−18.4% | Reduced | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 250,000 | $2.61M | 0.4% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 250,000 | $2.85M | 0.4% | −50,000−16.7% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 75,000 | $2.92M | 0.5% | −80,000−51.6% | Reduced | History |
| NKTXNkarta, Inc. | COM | 650,000 | $2.94M | 0.5% | +450,000+225.0% | Added | History |
| SVRASavara Inc | COM | 700,000 | $2.97M | 0.5% | −846,850−54.7% | Reduced | History |
| NXTCNextCure, Inc. | COM | 2,302,598 | $3.15M | 0.5% | +614,643+36.4% | Added | History |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $3.51M | 0.5% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 50,000 | $3.65M | 0.6% | −75,000−60.0% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 350,000 | $4.24M | 0.7% | +22,041+6.7% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 125,000 | $4.25M | 0.7% | −350,400−73.7% | Reduced | History |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $4.32M | 0.7% | – | New | – |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $4.42M | 0.7% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 147,500 | $4.73M | 0.7% | +77,501+110.7% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 600,000 | $5.00M | 0.8% | +600,000 | New | History |
| ARVNArvinas, Inc. | COM | 225,000 | $5.54M | 0.9% | +225,000 | New | History |
| PCVXVaxcyte, Inc. | COM | 50,000 | $5.71M | 0.9% | −10,000−16.7% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 325,000 | $6.30M | 1.0% | +275,000+550.0% | Added | History |
| IMVTImmunovant, Inc. | COM | 225,000 | $6.41M | 1.0% | −121,088−35.0% | Reduced | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 500,000 | $6.67M | 1.0% | −50,000−9.1% | Reduced | History |
| GERNGeron Corp | COM | 1,500,000 | $6.81M | 1.1% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 2,499,431 | $6.82M | 1.1% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 80,000 | $7.19M | 1.1% | 00.0% | Unchanged | History |
| CLYMClimb Bio, Inc. | COM | 1,500,000 | $7.63M | 1.2% | −170,661−10.2% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 300,000 | $7.64M | 1.2% | +200,000+200.0% | Added | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 472,390 | $7.84M | 1.2% | +49,235+11.6% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 35,000 | $7.86M | 1.2% | −75,000−68.2% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 725,106 | $7.98M | 1.2% | −250,500−25.7% | Reduced | History |
| MRUSMerus N.V. | COM | 161,741 | $8.08M | 1.3% | +36,741+29.4% | Added | History |
| RZLTRezolute, Inc. | COM NEW | 1,700,000 | $8.24M | 1.3% | −150,000−8.1% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 349,836 | $8.57M | 1.3% | +349,836 | New | History |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $9.62M | 1.5% | – | – | – |
| WVEWave Life Sciences, Inc. | SHS | 1,400,000 | $11.5M | 1.8% | +1,025,000+273.3% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 525,000 | $11.9M | 1.9% | +375,000+250.0% | Added | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 290,447 | $12.6M | 1.9% | +67,040+30.0% | Added | History |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $13.1M | 2.0% | – | – | – |
| KURAKura Oncology, Inc. | COM | 687,785 | $13.4M | 2.1% | +37,785+5.8% | Added | History |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $14.6M | 2.3% | – | – | – |
| SYRESpyre Therapeutics, Inc. | COM NEW | 498,420 | $14.7M | 2.3% | −15,000−2.9% | Reduced | History |
| INZYInozyme Pharma, Inc. | COM | 2,822,318 | $14.8M | 2.3% | −33,934−1.2% | Reduced | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 965,612 | $15.4M | 2.4% | −170,090−15.0% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 4,500,000 | $16.3M | 2.5% | +200,000+4.7% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 650,000 | $18.7M | 2.9% | −50,000−7.1% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 435,000 | $19.2M | 3.0% | +60,000+16.0% | Added | History |
| NRIXNurix Therapeutics, Inc. | COM | 860,399 | $19.3M | 3.0% | −51,601−5.7% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 400,000 | $20.4M | 3.2% | −115,000−22.3% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $21.2M | 3.3% | −10,000−9.1% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $25.2M | 3.9% | −50,000−3.4% | Reduced | History |
| ALKSAlkermes plc. | SHS | 1,000,000 | $28.0M | 4.3% | +350,000+53.8% | Added | History |
| ACLXArcellx, Inc. | COMMON STOCK | 400,000 | $33.4M | 5.2% | −60,000−13.0% | Reduced | History |
| NUVLNuvalent, Inc. | COM | 337,500 | $34.5M | 5.4% | +137,500+68.8% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 664,198 | $39.0M | 6.1% | −172,085−20.6% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,144,021 | $45.0M | 7.0% | +149,794+15.1% | Added | History |
Options (9)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| FLNAFilana Therapeutics, Inc. | COM | $42.7M | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $18.0M |
| ANABAnaptysbio, Inc | COM | $6.70M | – |
| SPRYARS Pharmaceuticals, Inc. | COM | – | $5.80M |
| NVAXNovavax Inc | COM NEW | – | $3.79M |
| GALTGalectin Therapeutics Inc | COM NEW | $3.33M | – |
| SMMTSummit Therapeutics Inc. | COM | – | $3.07M |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | $2.65M | – |
| IMVTImmunovant, Inc. | COM | – | $2.22M |
Sold out since Q2 2024 (20)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 500,000 | $20.4M | 3.2% | History |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $17.3M | 2.7% | – |
| Alnylam Pharmaceuticals, Inc.02043QAB3 | NOTE 1.000% 9/1 | – | $16.2M | 2.6% | – |
| MORFMorphic Holding, Inc. | COM | 250,573 | $8.54M | 1.3% | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,468,825 | $3.97M | 0.6% | History |
| HLVXHilleVax, Inc. | COM | 265,859 | $3.84M | 0.6% | History |
| DYNDyne Therapeutics, Inc. | COM | 100,000 | $3.53M | 0.6% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 37,550 | $3.48M | 0.5% | – |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 650,000 | $3.03M | 0.5% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 275,000 | $2.98M | 0.5% | History |
| VIRVir Biotechnology, Inc. | COM | 200,000 | $1.78M | 0.3% | History |
| ZYMEZymeworks Inc. | COM | 191,127 | $1.63M | 0.3% | History |
| MRSNMersana Therapeutics, Inc. | COM | 767,000 | $1.54M | 0.2% | History |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 133,500 | $1.53M | 0.2% | History |
| ADCTADC Therapeutics SA | SHS | 474,744 | $1.50M | 0.2% | History |
| TNGXTango Therapeutics, Inc. | COM | 150,274 | $1.29M | 0.2% | History |
| ORKAOruka Therapeutics, Inc. | COM | 72,484 | $277.6K | <0.1% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 75,000 | $228.8K | <0.1% | History |
| PASGPassage BIO, Inc. | COM | 264,266 | $209.9K | <0.1% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 100 | $802 | <0.1% | History |